Acadia Healthcare (NASDAQ:ACHC) Upgraded to “Hold” by ValuEngine

Acadia Healthcare (NASDAQ:ACHC) was upgraded by investment analysts at ValuEngine from a “sell” rating to a “hold” rating in a note issued to investors on Monday, ValuEngine reports.

Several other brokerages also recently issued reports on ACHC. Raymond James downgraded Acadia Healthcare from a “strong-buy” rating to an “outperform” rating and set a $45.00 price objective for the company. in a research report on Wednesday, July 31st. Jefferies Financial Group set a $40.00 price objective on Acadia Healthcare and gave the company a “buy” rating in a research report on Thursday, October 10th. BidaskClub downgraded Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Tuesday, October 8th. Zacks Investment Research downgraded Acadia Healthcare from a “hold” rating to a “sell” rating and set a $31.00 price objective for the company. in a research report on Wednesday, August 7th. Finally, UBS Group lifted their price objective on Acadia Healthcare from $29.00 to $34.00 and gave the company a “neutral” rating in a research report on Friday, September 20th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $36.30.

ACHC traded up $0.31 during trading on Monday, hitting $30.88. The company’s stock had a trading volume of 435,544 shares, compared to its average volume of 862,347. The firm’s 50 day moving average price is $30.05 and its two-hundred day moving average price is $31.22. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 1.53. Acadia Healthcare has a 12 month low of $24.27 and a 12 month high of $45.35. The stock has a market capitalization of $2.69 billion, a price-to-earnings ratio of 13.79, a price-to-earnings-growth ratio of 1.35 and a beta of 0.72.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Tuesday, July 30th. The company reported $0.61 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.59 by $0.02. Acadia Healthcare had a positive return on equity of 7.20% and a negative net margin of 6.80%. The firm had revenue of $789.00 million during the quarter, compared to the consensus estimate of $795.31 million. During the same quarter in the previous year, the company posted $0.70 EPS. The business’s revenue for the quarter was up 3.0% compared to the same quarter last year. On average, sell-side analysts forecast that Acadia Healthcare will post 2.13 earnings per share for the current year.

In other news, CEO Debra K. Osteen bought 20,000 shares of the company’s stock in a transaction dated Thursday, September 5th. The stock was bought at an average price of $26.53 per share, for a total transaction of $530,600.00. Following the completion of the transaction, the chief executive officer now directly owns 117,178 shares in the company, valued at approximately $3,108,732.34. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 2.60% of the company’s stock.

Hedge funds have recently added to or reduced their stakes in the company. Virginia Retirement Systems ET AL grew its stake in shares of Acadia Healthcare by 2.5% during the second quarter. Virginia Retirement Systems ET AL now owns 16,300 shares of the company’s stock worth $570,000 after purchasing an additional 400 shares during the period. Brinker Capital Inc. grew its stake in shares of Acadia Healthcare by 2.0% during the third quarter. Brinker Capital Inc. now owns 24,797 shares of the company’s stock worth $771,000 after purchasing an additional 476 shares during the period. Oregon Public Employees Retirement Fund grew its stake in shares of Acadia Healthcare by 1.4% during the second quarter. Oregon Public Employees Retirement Fund now owns 35,433 shares of the company’s stock worth $1,238,000 after purchasing an additional 506 shares during the period. UBS Asset Management Americas Inc. grew its stake in shares of Acadia Healthcare by 0.6% during the second quarter. UBS Asset Management Americas Inc. now owns 103,625 shares of the company’s stock worth $3,622,000 after purchasing an additional 572 shares during the period. Finally, MUFG Americas Holdings Corp grew its stake in shares of Acadia Healthcare by 127.4% during the second quarter. MUFG Americas Holdings Corp now owns 1,294 shares of the company’s stock worth $45,000 after purchasing an additional 725 shares during the period.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico.

Featured Article: What is the CBOE Russell 2000® Volatility Index?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.